CUSIP: 69242L106
Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
20,212,820
-
Share change
-
-934,439
-
Total reported value
-
$87,520,000
-
Price per share
-
$4.33
-
Number of holders
-
51
-
Value change
-
-$8,906,836
-
Number of buys
-
18
-
Number of sells
-
41
Quarterly Holders Quick Answers
What is CUSIP 69242L106?
CUSIP 69242L106 identifies OYST - OYSTER POINT PHARMA INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2022
-
Previous quarter:
Q1 2022
Recent filing periods for CUSIP 69242L106:
Institutional Holders of OYSTER POINT PHARMA INC - COMMON STOCK (OYST) as of Q2 2022
As of 30 Jun 2022,
OYSTER POINT PHARMA INC - COMMON STOCK (OYST) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,212,820 shares.
The largest 10 holders included
NEA Management Company, LLC, Invus Financial Advisors, LLC, RTW INVESTMENTS, LP, Point72 Asset Management, L.P., Paradigm Biocapital Advisors LP, Kohlberg Kravis Roberts & Co. L.P., Telemark Asset Management, LLC, VANGUARD GROUP INC, BlackRock Inc., and COWEN AND COMPANY, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.